Treatment of 95 post-Covid patients with SSRIs Post-Covid-19 syndrome (PCS) affects 12.5% of people, causing chronic fatigue, dysautonomia, and neurological issues. A study found that 95 PCS patients treated with selective serotonin reuptake inhibitors (SSRIs) experienced improved well-being. The response to SSRIs was explained by seven neurobiological mechanisms, including the metabolic kynurenine pathway (KP), which is overactive in PCS and maintains inflammation. Future research should explore potential avenues for further clinical research.
*********
Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis -Long COVID, a chronic condition affecting over 100 million people globally, has been studied using a combinatorial analysis approach to identify genetic variants associated with the development of the disease and examine the biological mechanisms underpinning its symptoms. The study compared two subpopulations of long COVID patients from Sano Genetics' Long COVID GOLD study cohort, focusing on patients with severe or fatigue dominant phenotypes. The analysis identified 73 genes highly associated with at least one of the long COVID populations, with 9 having prior associations with acute COVID-19 and 14 differentially expressed in a transcriptomic analysis of long COVID patients. The biological pathways most significantly associated with the 73 long COVID genes were mainly aligned with neurological and cardiometabolic diseases. The study found that 39 SNPs associated with long COVID can be linked to 9 genes identified in a recent combinatorial analysis of ME/CFS patient from UK Biobank.
*********

Comments
Post a Comment